Key result
Computational analysis identified 79 conserved regions, 106 conserved-structured regions, and 59 conserved-unstructured regions in the SARS-CoV-2 genome as potential targets for antivirals and diagnostics.
Why the study?
A compilation of conserved RNA genome regions and structural propensities in SARS-CoV-2 was needed to guide the development of antivirals and diagnostics.
These conserved regions require experimental validation before antiviral or diagnostic use; leaves open their clinical utility pending functional studies.
As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nucleotides as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences reported to date from the current COVID-19 outbreak, and we present a curated list of 30 'SARS-related-conserved' regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 'SARS-CoV-2-conserved-structured' regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the 5´ UTR, frame-shifting element, and 3´ UTR. Last, we predict regions of the SARS-CoV-2 viral genome have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 'SARS-CoV-2-conserved-unstructured' genomic regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Rangan et al. (2020) studied SARS-CoV-2. RNA sequence conservation and secondary structure analysis was evaluated. Computational analysis identified 79 conserved regions, 106 conserved-structured regions, and 59 conserved-unstructured regions in the SARS-CoV-2 genome as potential targets for antivirals and diagnostics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: